What is a stock summary page? Click here for an overview.
Business Description
Kainos Medicine Inc
ISIN : KR7284620002
Compare
Compare
Traded in other countries / regions
284620.Korea Index Membership
KOSDAQ Composite Index IPO Date
2018-06-08Description
Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.8 | |||||
| Equity-to-Asset | 0.17 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -16.06 | |||||
| Beneish M-Score | -1.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -60.9 | |||||
| 3-Year EBITDA Growth Rate | 48.8 | |||||
| 3-Year EPS without NRI Growth Rate | 48.3 | |||||
| 3-Year FCF Growth Rate | 47.6 | |||||
| 3-Year Book Growth Rate | -49.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.41 | |||||
| 9-Day RSI | 44.03 | |||||
| 14-Day RSI | 42.12 | |||||
| 3-1 Month Momentum % | -44.03 | |||||
| 6-1 Month Momentum % | -65.04 | |||||
| 12-1 Month Momentum % | -45.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.98 | |||||
| Quick Ratio | 0.98 | |||||
| Cash Ratio | 0.82 | |||||
| Days Sales Outstanding | 139.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.6 | |||||
| Shareholder Yield % | 2.54 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.46 | |||||
| Operating Margin % | -2088.17 | |||||
| Net Margin % | -2064.84 | |||||
| FCF Margin % | -1644.57 | |||||
| ROE % | -163.9 | |||||
| ROA % | -73.43 | |||||
| ROIC % | -152.89 | |||||
| 3-Year ROIIC % | 5.13 | |||||
| ROC (Joel Greenblatt) % | -1569.96 | |||||
| ROCE % | -104.98 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 54.48 | |||||
| PB Ratio | 17.97 | |||||
| Price-to-Tangible-Book | 24.97 | |||||
| EV-to-EBIT | -3.14 | |||||
| EV-to-EBITDA | -3.46 | |||||
| EV-to-Revenue | 65.26 | |||||
| EV-to-FCF | -3.75 | |||||
| Price-to-GF-Value | 0.2 | |||||
| Earnings Yield (Greenblatt) % | -31.78 | |||||
| FCF Yield % | -25.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kainos Medicine Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 590.367 | ||
| EPS (TTM) (â‚©) | -438 | ||
| Beta | 1.21 | ||
| 3-Year Sharpe Ratio | -0.84 | ||
| 3-Year Sortino Ratio | -0.99 | ||
| Volatility % | 79.65 | ||
| 14-Day RSI | 42.12 | ||
| 14-Day ATR (â‚©) | 112.616479 | ||
| 20-Day SMA (â‚©) | 1208.9 | ||
| 12-1 Month Momentum % | -45.95 | ||
| 52-Week Range (â‚©) | 1052 - 7100 | ||
| Shares Outstanding (Mil) | 32.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kainos Medicine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kainos Medicine Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kainos Medicine Inc Frequently Asked Questions
What is Kainos Medicine Inc(XKRX:284620)'s stock price today?
The current price of XKRX:284620 is â‚©1155.00. The 52 week high of XKRX:284620 is â‚©7100.00 and 52 week low is â‚©1052.00.
When is next earnings date of Kainos Medicine Inc(XKRX:284620)?
The next earnings date of Kainos Medicine Inc(XKRX:284620) is .
Does Kainos Medicine Inc(XKRX:284620) pay dividends? If so, how much?
Kainos Medicine Inc(XKRX:284620) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers